<p>(A and B) Longitudinal analyses of the dynamics of human CD4<sup>+</sup> T cell subsets in the PB of infected humanized mice. The numbers of total CD4<sup>+</sup> T cells (CD45<sup>+</sup> CD3<sup>+</sup> CD4<sup>+</sup> cells), Tns (CD45<sup>+</sup> CD3<sup>+</sup> CD4<sup>+</sup> CD45RA<sup>+</sup> FOXP3<sup>−</sup> cells), Tms (CD45<sup>+</sup> CD3<sup>+</sup> CD4<sup>+</sup> CD45RA<sup>−</sup> FOXP3<sup>−</sup> cells), and Tregs (CD45<sup>+</sup> CD3<sup>+</sup> CD4<sup>+</sup> CD45RA<sup>−</sup> FOXP3<sup>+</sup> cells) in the PB of R5 WT HIV-1-infected mice (n = 8), R5 <i>vpr</i>-deficient HIV-1-infected mice (n = 8), and mock-infected mice (n = 12) were routinely quantified by flow cytometry and hematocytometry. Summarized results...
<p>(<b>A, B</b>) RNA-seq of the splenic human MNCs of infected humanized mice. (<b>A</b>) RNA-seq. R...
<p>(A and B) The virus solutions containing 5 ng of p24 antigen (WT HIV-1 [n = 7], 4A HIV-1 [n = 11]...
<p>Humanized mice were infected HIV-JRCSF and were treated weekly with 15B or control at 11 weeks po...
<p>(A and B) CXCR4 expression on CD4<sup>+</sup> T cell subsets in human and humanized mouse. Human ...
<p>Human CD4<sup>+</sup> T cells isolated from the spleen of humanized mice (A and C, n = 8) and the...
<p>(A) Viral load in infected humanized mice. The amounts of viral RNA in the plasma of R5 WT HIV-1-...
<div><p>(A) Comparison of the levels of CD4<sup>+</sup> or CD8<sup>+</sup> human T cells in the GALT...
<p>hNOK/B51Tg and hNOK mice were infected or not with HIV-1 at 14 weeks after the transplantation of...
<p>(A to D) Evaluation of Treg depletion by treatment with DD. DD was administrated into humanized m...
<div><p>(A) Comparison of the levels of human CD4<sup>+</sup>CCR5<sup>+</sup> T cells in the indicat...
<div><p>(A) Comparison of the levels of CD4<sup>+</sup> or CD8<sup>+</sup> human T cells in the indi...
(A) Experimental design of HIV infection and anti-CD4 antibody treatment in humanized mice. The freq...
<p>(A) Changes in the percentage of CCR5<sup>+</sup> (left) and CXCR4<sup>+</sup> (right) cells with...
An essential branch of the adaptive immune system is formed by T cells which are produced in the thy...
<p>NOK/B51Tg mice were established by backcrossing NOK mice with HLA-B*51:01 transgenic NOD/SCID mic...
<p>(<b>A, B</b>) RNA-seq of the splenic human MNCs of infected humanized mice. (<b>A</b>) RNA-seq. R...
<p>(A and B) The virus solutions containing 5 ng of p24 antigen (WT HIV-1 [n = 7], 4A HIV-1 [n = 11]...
<p>Humanized mice were infected HIV-JRCSF and were treated weekly with 15B or control at 11 weeks po...
<p>(A and B) CXCR4 expression on CD4<sup>+</sup> T cell subsets in human and humanized mouse. Human ...
<p>Human CD4<sup>+</sup> T cells isolated from the spleen of humanized mice (A and C, n = 8) and the...
<p>(A) Viral load in infected humanized mice. The amounts of viral RNA in the plasma of R5 WT HIV-1-...
<div><p>(A) Comparison of the levels of CD4<sup>+</sup> or CD8<sup>+</sup> human T cells in the GALT...
<p>hNOK/B51Tg and hNOK mice were infected or not with HIV-1 at 14 weeks after the transplantation of...
<p>(A to D) Evaluation of Treg depletion by treatment with DD. DD was administrated into humanized m...
<div><p>(A) Comparison of the levels of human CD4<sup>+</sup>CCR5<sup>+</sup> T cells in the indicat...
<div><p>(A) Comparison of the levels of CD4<sup>+</sup> or CD8<sup>+</sup> human T cells in the indi...
(A) Experimental design of HIV infection and anti-CD4 antibody treatment in humanized mice. The freq...
<p>(A) Changes in the percentage of CCR5<sup>+</sup> (left) and CXCR4<sup>+</sup> (right) cells with...
An essential branch of the adaptive immune system is formed by T cells which are produced in the thy...
<p>NOK/B51Tg mice were established by backcrossing NOK mice with HLA-B*51:01 transgenic NOD/SCID mic...
<p>(<b>A, B</b>) RNA-seq of the splenic human MNCs of infected humanized mice. (<b>A</b>) RNA-seq. R...
<p>(A and B) The virus solutions containing 5 ng of p24 antigen (WT HIV-1 [n = 7], 4A HIV-1 [n = 11]...
<p>Humanized mice were infected HIV-JRCSF and were treated weekly with 15B or control at 11 weeks po...